Our results found that the expression of p-Tyr216-GSK-3β and p-β-catenin, the ratio of p-Tyr216-GSK-3β/GSK-3β and p-β-catenin/β-catenin in the brain of AD mice all increased significantly. The gene discussed is GSK3B; the disease is Alzheimer disease.